Not applicableStudy completedNCT00186303What this trial is testingTransplantation for Patients With Chronic Lymphocytic LeukemiaWho this might be right forLeukemia, Lymphocytic, Chronic Stanford University 28
Testing effectiveness (Phase 2)Ended earlyNCT00121186What this trial is testingS0501 Fludarabine, Melphalan, and Donor Stem Cell Transplant Followed By Tacrolimus and Methotrexate in Treating Patients for Relapsed LymphomaWho this might be right forLymphoma SWOG Cancer Research Network 1
Early research (Phase 1)Study completedNCT00515983What this trial is testingVaccination of Melanoma Patients With Dendritic Cells Loaded With Allogeneic Apoptotic-Necrotic Melanoma CellsWho this might be right forMelanoma José Mordoh, M.D., Ph.D. 16
Post-approval studies (Phase 4)Study completedNCT02747615What this trial is testingEfficacy of Preoperative Autologous Blood Donation and Tranexamic Acid in Revision Total Hip ArthroplastyWho this might be right forRevision Total Hip Arthroplasty (RTHA) Ain Shams University 60
Not applicableStudy completedNCT00839241What this trial is testingA Clinical Study to Investigate if Transfusion of Patients Own Shed Blood Improves the Immunological Status in Comparison to Transfusion of Donor Blood ("Bank Blood")Who this might be right forArthroplasty, Replacement, KneeBlood Transfusion, AutologousBlood Transfusion Wellspect HealthCare 45
Early research (Phase 1)UnknownNCT05640713What this trial is testingAssessment of Safety and Efficacy of ThisCART19A in Adult Patients With B Cell Malignancies After Failure of Autologous Chimeric Antigen Receptor T- Cell(CAR-T) TherapyWho this might be right forAllogeneic, CAR-T, Protein Sequestration, Non-gene Edited Henan Cancer Hospital 12
Testing effectiveness (Phase 2)Study completedNCT00050323What this trial is testingSafety/Efficacy of a Vaccine Prepared From Dendritic Cells Combined With Tumor Cells to Treat Advanced Kidney CancerWho this might be right forCarcinoma, Renal Cell Genzyme, a Sanofi Company 30
Testing effectiveness (Phase 2)UnknownNCT01883518What this trial is testingAutologous Dendritic Cell Vaccine in Patients With Soft Tissue SarcomaWho this might be right forSarcomaNeoplasms, Connective and Soft Tissue N.N. Petrov National Medical Research Center of Oncology 48
Testing effectiveness (Phase 2)UnknownNCT02145923What this trial is testingEffectiveness and Safety of MMSCs for Enhancing Hematopoietic Recovery and Prophylaxis of Neutropenic EnterocolitisWho this might be right forNeutropenic EnterocolitisMyeloablative Chemotherapy Induced Bone Marrow Aplasia Burnasyan Federal Medical Biophysical Center 16
Large-scale testing (Phase 3)Not Yet RecruitingNCT07064954What this trial is testingAutologous Cold-stored Apheresis PlateletsWho this might be right forBleedingPlateletsCardiopulmonary Bypass+1 more University Health Network, Toronto 100
Not applicableStudy completedNCT01278927What this trial is testingExercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)Who this might be right forPhysiological Stress Medical College of Wisconsin 711
Not applicableStudy completedNCT05352789What this trial is testingNutrition and Metabolic Prehabilitation in HSCT Patients UK and ROI. BSBMT Multi-centre Survey.Who this might be right forHaematological MalignancyBone Marrow Transplant ComplicationsStem Cell Transplant Complications+4 more Nottingham University Hospitals NHS Trust 66
Testing effectiveness (Phase 2)Study completedNCT00625755What this trial is testingA Phase I/II Study to Assess the Safety and Efficacy of Vaccinations With Allogeneic Dendritic Cells: Autologous Tumor-Derived Cells Subjected to Electrofusions in Patients With AJCC Stage IV Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma Beth Israel Deaconess Medical Center 40
Testing effectiveness (Phase 2)Study completedNCT00116467What this trial is testingVaccination in the Peripheral Stem Cell Transplant Setting for Acute Myelogenous LeukemiaWho this might be right forAcute Myelogenous Leukemia Cell Genesys 55
Testing effectiveness (Phase 2)Active Not RecruitingNCT05664243What this trial is testingA Phase 1b / 2 Drug Resistant Immunotherapy With Activated, Gene Modified Allogeneic or Autologous γδ T Cells (DeltEx) in Combination With Maintenance Temozolomide in Subjects With Recurrent or Newly Diagnosed GlioblastomaWho this might be right forGlioblastoma In8bio Inc. 4
Early research (Phase 1)Active Not RecruitingNCT00368082What this trial is testingAutologous/Allogeneic TGFbeta-resistant LMP-specific CTL, Lymphoma (TGF-beta)Who this might be right forLymphomaHodgkin's DiseaseRelapse+1 more Baylor College of Medicine 8
Testing effectiveness (Phase 2)Study completedNCT00005803What this trial is testingAutologous Stem Cell Transplant Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory LymphomaWho this might be right forProlymphocytic LeukemiaRecurrent Adult Hodgkin LymphomaRecurrent Childhood Hodgkin Lymphoma+11 more Fred Hutchinson Cancer Center 76
Testing effectiveness (Phase 2)Study completedNCT02168101What this trial is testingDetermining the Feasibility of MLN9708 as Maintenance After Allogeneic Stem Cell Transplant for Multiple MyelomaWho this might be right forMultiple Myeloma SCRI Development Innovations, LLC 9
Not applicableUnknownNCT00231712What this trial is testingImmuno 1: Immune Reconstitution Following Conventional or High-Dose Chemotherapy With Stem Cell TransplantWho this might be right forLeukemiaMedulloblastoma Julius-Maximilians University 50
Testing effectiveness (Phase 2)Study completedNCT00781170What this trial is testingDose-Reduced Allogeneic Stem Cell Transplantation After Autologous High-Dose Chemotherapy in Patients With Multiple MyelomaWho this might be right forMultiple MyelomaStem Cell Transplantation Universitätsklinikum Hamburg-Eppendorf 20